This trial is testing whether Vitamin E can help people with HIV who also have a fatty liver by seeing if the underlying liver condition gets better, worse, or stays the same.
1 Primary · 3 Secondary · Reporting Duration: at randomization visit (study day 1) and end of study visit (week 24)
56 Total Participants · 2 Treatment Groups
Primary Treatment: Group A · Has Placebo Group · Phase 2
Age 18 - 75 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: